Previous close | 0.0400 |
Open | 0.0600 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 145.00 |
Expiry date | 2024-06-21 |
Day's range | 0.0400 - 0.0600 |
Contract range | N/A |
Volume | |
Open interest | N/A |
RAHWAY, N.J., June 05, 2024--Merck to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
RAHWAY, N.J., May 29, 2024--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has accepted for priority review a new supplemental Biologics License Application (sBLA) seeking approval for KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with chemotherapy, for the first-line treatment of patients with unresectable advanced or metastatic malignant pleural mesothelioma. The FDA has set a Prescription Drug User Fee